Achieve Life Sciences ACHV
NASDAQ ACHV
$6.50 -0.01 (-0.15%)
As of: Oct 21, 2026 · 10:27 AM EDT

Achieve Life Sciences (ACHV) EV to EBITDA (2012)

Updated

Achieve Life Sciences' EV to EBITDA was 9.49 in Q3 2012.

Analysis

Achieve Life Sciences (ACHV) EV to EBITDA (2012) Analysis & Trends

On a trailing twelve-month basis, Achieve Life Sciences' EV to EBITDA was -11.71 through Sep 30, 2012.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,132.34 Bn 1,100.93 Bn 19.71 Bn
2 Johnson & Johnson 615.91 Bn 534.44 Bn 17.26 Bn
3 AbbVie 505.47 Bn 478.59 Bn 12.70 Bn
4 Merck 368.25 Bn 322.63 Bn 12.21 Bn
5 Novartis Ag 298.18 Bn 262.17 Bn 11.24 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn
7 Amgen 236.22 Bn 191.62 Bn 7.24 Bn
8 Gilead Sciences 190.68 Bn 164.87 Bn 6.22 Bn
9 Pfizer 170.14 Bn 116.79 Bn 10.94 Bn
10 Achieve Life Sciences 600.34 Mn 413.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 9.49
API Access

Achieve Life Sciences EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ACHV&period=max&api_key=YOUR_API_KEY